Physician profile
Albert M Edwards
NPI 1265505531
$3,378.09
in general payments reported to CMS, 2019-2025
8 companies · $565 in 2025
The $565 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $220 · 2021: $407 · 2022: $578 · 2023: $117 · 2024: $1,196 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286 · Travel and Lodging: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.28 |
| Travel and Lodging | $591.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,426.67 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $986.55 | 2020-2025 | Wegovy |
| Intuitive Surgical, INC. | $591.11 | 2024 | |
| Lilly USA, LLC | $95.25 | 2024 | Mounjaro |
| Glaxosmithkline, LLC. | $85.08 | 2021 | |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Scilex Pharmaceuticals INC. | $56.72 | 2019 | |
| Kaleo, INC. | $52.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.